MERETEK UBT KIT (W Drug Patent Profile
When do Meretek Ubt Kit (w patents expire, and when can generic versions of Meretek Ubt Kit (w launch?
Meretek Ubt Kit (w is a drug marketed by Otsuka America and is included in one NDA.
The generic ingredient in MERETEK UBT KIT (W is urea c-13. There is one drug master file entry for this compound. Additional details are available on the urea c-13 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MERETEK UBT KIT (W?
- What are the global sales for MERETEK UBT KIT (W?
- What is Average Wholesale Price for MERETEK UBT KIT (W?
Summary for MERETEK UBT KIT (W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | MERETEK UBT KIT (W at DailyMed |
US Patents and Regulatory Information for MERETEK UBT KIT (W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka America | MERETEK UBT KIT (W/ PRANACTIN) | urea c-13 | FOR SOLUTION;ORAL | 020586-001 | Sep 17, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
